High blood pressure screening in pharmacies during May Measurement Month campaigns in Switzerland

References

• World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: World Health Organization; 2009.
   Google Scholar
• Collaboration NCDRF. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):129–980.
   Web of Science ®Google Scholar
• WHO. A global brief on hypertension: Silent killer, global public health crisis. Geneva, Switzerland: World Health Organization; 2013.
   Google Scholar
• Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American heart association. Circulation. 2020;141(9):e139–e596.
   PubMed Web of Science ®Google Scholar
• Neuhauser H, Adler C, Sarganas G. Selective blood pressure screening in the young: quantification of population wide underestimation of elevated blood pressure. Int J Hypertens. 2019;2019:1–8.
   Web of Science ®Google Scholar
• Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, Middle-, and low-income countries. JAMA. 2013;310(9):959–968.
   PubMed Web of Science ®Google Scholar
• Kotseva K, De Backer G, De Bacquer D, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European society of cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019;26(8):824–835.
   PubMed Web of Science ®Google Scholar
• Danon-Hersch N, Marques-Vidal P, Bovet P, et al. Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Eur J Cardiovasc Prevent Rehabil. 2009;16(1):66–72.
   PubMedGoogle Scholar
• Guessous I, Bochud M, Theler J-M, et al. 1999–2009 Trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland. PLoS One. 2012;7(6):e39877.
   PubMed Web of Science ®Google Scholar
• Glatz N, Chappuis A, Conen D, et al. Associations of sodium, potassium and protein intake with blood pressure and hypertension in Switzerland. Swiss Med Wkly. 2017;147:w14411.
   PubMed Web of Science ®Google Scholar
• Nwabuo CC, Dy SM, Weeks K, et al. Factors associated with appointment non-adherence among African-Americans with severe, poorly controlled hypertension. PLoS One. 2014;9(8):e103090.
   PubMed Web of Science ®Google Scholar
• Macharia WM, Leon G, Rowe BH, et al. An overview of interventions to improve compliance with appointment keeping for medical services. JAMA. 1992;267(13):1813–1817.
   PubMed Web of Science ®Google Scholar
• Reeves L, Robinson K, McClelland T, et al. Pharmacist interventions in the management of blood pressure control and adherence to antihypertensive medications: a systematic review of randomized controlled trials. J Pharm Pract. 2020;34:480–492.
   PubMed Web of Science ®Google Scholar
• Frazier KR, McKeirnan KC, Kherghehpoush S, et al. Rural patient perceptions of pharmacist-provided chronic condition management in a state with provider status. J Am Pharm Assoc. 2019;59(2):210–216.
   Google Scholar
• Jokanovic N, Tan EC, Sudhakaran S, et al. Pharmacist-led medication review in community settings: an overview of systematic reviews. Res Social Adm Pharm. 2017;13(4):661–685.
   PubMed Web of Science ®Google Scholar
• Albasri A, OʼSullivan JW, Roberts NW, et al. A comparison of blood pressure in community pharmacies with ambulatory, home and general practitioner office readings: systematic review and Meta-analysis. J Hypertens. 2017;35(10):1919–1928.
   PubMed Web of Science ®Google Scholar
• Organization WH. Pharmacy-based hypertension management model: protocol and guidelines: a joint CINDI/EuroPharm forum project. Copenhagen: WHO Regional Office for Europe; 2005.
   Google Scholar
• Al-Makki A, DiPette D, Whelton PK, et al. Hypertension pharmacological treatment in adults: a world health organization guideline executive summary. Hypertension. 2022;79(1):293–301.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):1269–1324.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Palatini P, Parati G, et al. 2021 European society of hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39:1293–1302.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–1499.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the european society of hypertension. J Hypertens. 2018;36(10):1953–2041.
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Palatini P, Parati G, et al. 2021 European society of hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293–1302.
   PubMed Web of Science ®Google Scholar
• Beaney T, Schutte AE, Tomaszewski M, et al. May measurement month 2017: an analysis of blood pressure screening results worldwide. Lancet Global Health. 2018;6(7):e736–e743. e43.
   PubMed Web of Science ®Google Scholar
• Waszyk-Nowaczyk M, Guzenda W, Plewka B, et al. Screening services in a community pharmacy in Poznan (Poland) to increase early detection of hypertension. J Clin Med. 2020;9(8):2572.
   Web of Science ®Google Scholar
• Schulz M, Griese-Mammen N, Schumacher PM, et al. Development and implementation of blood pressure screening and referral guidelines for german community pharmacists. J Clin Hypertens. 2020;22(10):1807–1816.
   Web of Science ®Google Scholar
• Botomino A, Martina B, Ruf D, et al. White coat effect and white coat hypertension in community pharmacy practice. Blood Press Monit. 2005;10(1):13–18.
   PubMed Web of Science ®Google Scholar
• Karwalajtys T, Kaczorowski J, Hutchison B, et al. Blood pressure variability and prevalence of hypertension using automated readings from multiple visits to a pharmacy-based community-wide programme. J Hum Hypertens. 2009;23(9):585–589.
   PubMed Web of Science ®Google Scholar
• Boivin JM, Risse J, Lauriere E, et al. Screening for hypertension at the hairdresser: a feasibility study in France and Morocco. Blood Press. 2020;29(4):202–208.
   PubMed Web of Science ®Google Scholar
• Hess PL, Reingold JS, Jones J, et al. Barbershops as hypertension detection, referral, and follow-up centers for black men. Hypertension. 2007;49(5):1040–1046.
   PubMed Web of Science ®Google Scholar
• Walther D, Curjuric I, Dratva J, et al. High blood pressure: prevalence and adherence to guidelines in a population-based cohort. Swiss Med Wkly. 2016;146:w14323.
   PubMed Web of Science ®Google Scholar
• Fidalgo ASQ, Vollenweider P, Marques-Vidal P. Ten-year incidence of hypertension in a Swiss population-based sample incidence of hypertension in Switzerland. J Hum Hypertens. 2019;33(2):115–122.
   PubMed Web of Science ®Google Scholar
• Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
   PubMed Web of Science ®Google Scholar
• Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of Population-Based studies from 90 countries. Circulation. 2016;134(6):441–450.
   PubMed Web of Science ®Google Scholar
• Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3(8):e003423.
   PubMed Web of Science ®Google Scholar
• Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3(2):e000718.
   PubMed Web of Science ®Google Scholar
• Santschi V, Wuerzner G, Pais B, et al. Team-Based care for improving hypertension management: a pragmatic randomized controlled trial. Front Cardiovasc Med. 2021;8:760662.
   PubMed Web of Science ®Google Scholar
• Burnier M, Egan BM. Adherence in hypertension: a review of prevalence, risk factors, impact, and management. Circ Res. 2019;124(7):1124–1140.
   PubMed Web of Science ®Google Scholar
• Santschi V, Chiolero A, Burnand B, et al. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med. 2011;171(16):1441–1453.
   PubMedGoogle Scholar
• Santschi V, Chiolero A, Paradis G, et al. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2012;35(12):2706–2717.
   PubMed Web of Science ®Google Scholar
• Carter BL, Rogers M, Daly J, et al. The potency of team-based care interventions for hypertension: a Meta-analysis. Arch Intern Med. 2009;169(19):1748–1755.
   PubMedGoogle Scholar
• Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563–2571.
   PubMed Web of Science ®Google Scholar
• Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132–140.
   PubMed Web of Science ®Google Scholar
• Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy. 2002;22(12):1533–1540.
   PubMed Web of Science ®Google Scholar
• Sendra-Lillo J, Sabater-Hernandez D, Sendra-Ortola A, et al. Comparison of the white-coat effect in community pharmacy versus the physician’s office: the Palmera study. Blood Press Monit. 2011;16(2):62–66.
   PubMed Web of Science ®Google Scholar
• Sabater-Hernandez D, de la Sierra A, Sanchez-Villegas P, et al. Magnitude of the white-coat effect in the community pharmacy setting: the MEPAFAR study. Am J Hypertens. 2011;24(8):887–892.
   PubMed Web of Science ®Google Scholar
• Falaschetti E, Mindell J, Knott C, et al. Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet. 2014;383(9932):1912–1919.
   PubMed Web of Science ®Google Scholar
• Linderman GC, Lu J, Lu Y, et al. Association of body mass index with blood pressure among 1.7 million Chinese adults. JAMA Netw Open. 2018;1(4):e181271.
   PubMed Web of Science ®Google Scholar
• Rockwood MR, Howlett SE. Blood pressure in relation to age and frailty. Can Geriatr J. 2011;14(1):2–7.
   PubMedGoogle Scholar
• Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012;3(1):7.
   PubMed Web of Science ®Google Scholar
• Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008;52(5):818–827.
   PubMed Web of Science ®Google Scholar
• Gmel GK, Notari L, Gmel C. Monitorage suisse des addictions: consommation d’alcool, tabac et drogues illégales en Suisse en 2016–2017. Addiction Suisse, Lausanne, Suisse. https://www.suchtmonitoring.ch/docs/library/gmel_2tl0igxj1e6t.pdf
   Google Scholar
• Gerc V, Favrat B, Brunner HR, et al. Is nurse-measured blood pressure a valid substitute for ambulatory blood pressure monitoring? Blood Press Monit. 2000;5(4):203–209.
   PubMed Web of Science ®Google Scholar